Professional Documents
Culture Documents
MODULE I
INTRODUCTION TO PHARMACOLOGY
Lesson 2 Pharmacological
Considerations in IVT
MODULE I
INTRODUCTION TO PHARMACOLOGY
INTRODUCTION
This module sets the scene by describing the state of the evidence based in midwifery
pharmacology; it continues with an account of pharmacological principles, terms and definitions
as they relate to midwifery practice. It also outlines the extra considerations involved when
intravenous (IV) drug administration is undertaken outside specialist intensive care facilities.
Lastly, it describes the statutory framework for the control of medicines and discusses the
implications for midwives.
LEARNING OUTCOMES
There are three (3) lessons in Module 1. Read the lesson carefully then answer the given
exercise after each lesson. This is to assess your understanding and/or to augment your
learnings. Work on these exercises carefully and submit your output as advised by your
instructor.
In case you encounter difficulty, discuss this with me anytime via messenger or email.
If not, set an appointment with me to talk your concerns at the CCHAMS faculty office.
Lesson 1
PRINCIPLES OF PHARMACOLOGY
Pharmacology
The study of the actions of drugs, incorporating knowledge from other interrelated
sciences, such as pharmacokinetics (how the body absorbs, distributes, metabolizes, and
excretes a drug) and pharmacodynamics (a drug’s mechanism of action and effect on an
organism).
Drug Classifications
Drugs are classified by how they affect certain body systems, such as the use of
bronchodilators for respiratory conditions; by their therapeutic use, such as anti-nausea; or
based on their chemical characteristics, such as beta-blockers.
Drug Names
Midwives must know both the trade name of a drug, which is assigned by the
pharmaceutical company that manufactures the drug, and the generic name, which is the
official drug name and is not protected by trademark.
Drug Nomenclature
Every drug has (at least) three names:
1. Chemical Name – a scientific name that precisely describes the drug’s atomic
and molecular structure.
2. Generic Name or nonproprietary name or official name - an abbreviation of the
chemical name and it refers to a common established name regardless of its
manufacturer. There is only one generic name for a drug.
3. Brand Name (there can be one or more proprietary or trade names) – it is selected
by the drug company selling the product. Trade names are protected by
copyright. The symbol ® after a trade name indicates that the name is registered
by and restricted to the drug manufacturer.
Drugs Derivation
Drugs and biologic products are derived from 4 main sources:
1. Plants: examples of which are digitalis
2. Animals and human: from which drugs such as insulin, epinephrine are obtained
3. Minerals or mineral products: examples such as iodine and iron
4. Chemicals: made in laboratories
I. Local Route: applied to a localized area of the body or to the surface of a body part
regardless of the location of the effect.
II. Enteral Routes: any administration that makes use of the GIT to administer the drug
II. Parenteral Routes: any administration that avoids the used of the GIT to administer
the drug
Drug Therapy
The interactions between the drug and the person receiving it can be divided into four
stages:
• Getting the drug into the body – pharmaceuticals
• Getting the drug around, about and out of the body – pharmacokinetics
• Actions of the drug on the body – pharmacodynamics
• Effects of the drug on the person – therapeutics
b) Drug Formulation
The storage requirements of each preparation depend on the
formulation. Therefore, the data sheet for each product and brand should be
consulted for instructions on storage.
The LADME scheme (Figure 4) describes the pharmacokinetic processes which follow a
given dosage regimen. LADME processes can be divided into two classes, drug input (liberation
and absorption) and drug output (distribution, metabolism and excretion)
(http://www.rxkinetics.com/).
Therapeutic Range
Every drug has a therapeutic range or a desirable range for the concentration of drug in
plasma. Above the therapeutic range, toxic effects may appear. Below the therapeutic range,
the drug does not have the desired effect. For some drugs this range is very narrow, and the
therapeutic concentration is very close to the concentration at which adverse effects appear.
The body handles all drugs in three stages and are affected to some extent by pregnancy.
1. Absorption
The process by which a drug is made available to the body fluids for
distribution. The absorption of a drug will depend on the route of administration,
formulation, and the way the drug molecules move across cell membranes
throughout the body. Important barriers to drug absorption and distribution
include: the gut wall, capillary walls, cell membranes, the blood/brain barrier,
the placenta, the blood/milk barrier.
2. Distribution
Distribution is the movement of the drug around the body. It is affected
by: a) plasma protein binding; b) the lipid solubility of the drug (that is whether
it dissolves in fatty tissues); c) the binding properties of the drug; d) blood flow
to the organs and the state of the circulation; e) stage of life cycle, for example
pregnancy, infancy; f) disease state, for example pre-eclampsia or heart failure
3. Elimination or Clearance
The route of elimination varies with individual drugs. Some drugs are
eliminated unchanged whereas others are extensively metabolized. Most drugs
are excreted via the kidneys, although the bile is also an important route of
excretion. Many drugs are passed into breast milk. Alcohol is unusual in that 5–
10 percent is eliminated unchanged via the lungs, sweat and urine. For most
drugs, elimination involves metabolism in the liver plus excretion by the kidneys.
• Non-specific actions
Some drugs are presumed to act by virtue of their physiochemical
properties, rather than as a result of the specific shape of their molecules. For
example, antacids such as sodium bicarbonate or aluminum hydroxide neutralize
gastric secretions without acting on the cells of the body.
Clinical Effects
Clinical response shows considerable individual variation. This is not always
entirely predictable, and idiosyncratic reactions can occur. For example, some women
are unduly sensitive to oxytocin, and therefore infusions are commenced using a very
low dose (BNF, 2000). Clinical effects also depend upon age, gender, pregnancy, disease
state, drug interactions, weight, height, and genetic make-up. For example, women
generally require lower doses of drugs than men, even when body weight is taken into
consideration.
Side Effects
Side effects are adverse drug reactions that occur within the normal range of
therapeutic doses. Most drugs have potential side effects. These can be grouped under
the headings:
• Related to the Drug’s Main Actions
These are often the drug’s main side effects. Severity is usually related
to the dose administered. Since such side effects are often highly significant
and entirely predictable, appropriate monitoring systems must be in place.
For example, unless adequate checks are undertaken anti-coagulants can
cause bleeding, and insulin can cause hypoglycemia. With other drugs, the
link between drug actions and side effects is less obvious and requires rather
more understanding of physiology.
✓ Hypersensitivity Responses
A hypersensitivity response is possible with almost all drugs,
although antimicrobials are particular offenders. Individuals with a
history of atopic disorders, such as asthma or eczema, are particularly
vulnerable.
Most drugs or their metabolites can combine with carrier proteins
in the circulation to form immunogens, substances which produce an
immune response. This may affect any one of several organs such as
skin, liver or bone marrow. The severity of the hypersensitivity
response is also variable, ranging from a temporary skin rash to life-
threatening aplastic anemia.
✓ Cell Damage
Some drugs can cause direct damage to cells. For example, in
large doses, paracetamol (acetaminophen) can damage the liver and
kidneys. Other drugs, such as components of tobacco, damage cells by
altering the DNA regulating oncogenes which control cell division.
Drug-induced teratogenesis is a result of cell damage. The risks of
fetal damage depend on several factors as well as the chemical
composition of the drug (Lipkin, 1993):
• The stage of pregnancy
• The amount of drug ingested
• The number of doses – a single dose may be less damaging than
repeated exposure
• Other agents to which mother and fetus are exposed
• The mother’s nutritional status
• The genetic makeup of mother and fetus.
EXERCISE
Instruction: In a separate sheet, answer the following questions briefly.